Tech Company Financing Transactions
Heidelberg Epignostix Funding Round
On 7/8/2024, Heidelberg Epignostix secured $4.6 million in Seed investment from Carma Fund, High-Tech Gründerfonds and LBBW VC.
Transaction Overview
Company Name
Announced On
7/8/2024
Transaction Type
Venture Equity
Amount
$4,600,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand its development efforts for its flagship indication for brain tumor classification.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Köpfelweg 58
Heidelberg, 69118
Germany
Heidelberg, 69118
Germany
Phone
Undisclosed
Website
Email Address
Overview
We are Heidelberg Epignostix, a pioneering start-up composed of a dedicated team of experts in the field of DNA methylation-based tumor classification. Based in Heidelberg, Germany, our company is built upon the rich knowledge and extensive research experience of our team.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Jones
Browse more venture capital transactions:
Prev: 7/8/2024: Polystyvert venture capital transaction
Next: 7/8/2024: PreActiv venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs